_version_ 1783526693705613312
author Qu, Lihui
Lu, Yingying
Ying, Meike
Li, Bingjue
Weng, Chunhua
Xie, Zhoutao
Liang, Ludan
Lin, Chuan
Yang, Xian
Feng, Shi
Wang, Yucheng
Shen, Xiujin
Zhou, Qin
Chen, Ying
Chen, Zhimin
Wu, Jianyong
Lin, Weiqiang
Shen, Yi
Qin, Jing
Xu, Hang
Xu, Feng
Wang, Junwen
Chen, Jianghua
Jiang, Hong
Huang, Hongfeng
author_facet Qu, Lihui
Lu, Yingying
Ying, Meike
Li, Bingjue
Weng, Chunhua
Xie, Zhoutao
Liang, Ludan
Lin, Chuan
Yang, Xian
Feng, Shi
Wang, Yucheng
Shen, Xiujin
Zhou, Qin
Chen, Ying
Chen, Zhimin
Wu, Jianyong
Lin, Weiqiang
Shen, Yi
Qin, Jing
Xu, Hang
Xu, Feng
Wang, Junwen
Chen, Jianghua
Jiang, Hong
Huang, Hongfeng
author_sort Qu, Lihui
collection PubMed
description
format Online
Article
Text
id pubmed-7185064
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-71850642020-05-01 Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients Qu, Lihui Lu, Yingying Ying, Meike Li, Bingjue Weng, Chunhua Xie, Zhoutao Liang, Ludan Lin, Chuan Yang, Xian Feng, Shi Wang, Yucheng Shen, Xiujin Zhou, Qin Chen, Ying Chen, Zhimin Wu, Jianyong Lin, Weiqiang Shen, Yi Qin, Jing Xu, Hang Xu, Feng Wang, Junwen Chen, Jianghua Jiang, Hong Huang, Hongfeng Oncotarget Correction Impact Journals LLC 2020-04-21 /pmc/articles/PMC7185064/ /pubmed/32363004 http://dx.doi.org/10.18632/oncotarget.27561 Text en Copyright: © 2020 Qu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Qu, Lihui
Lu, Yingying
Ying, Meike
Li, Bingjue
Weng, Chunhua
Xie, Zhoutao
Liang, Ludan
Lin, Chuan
Yang, Xian
Feng, Shi
Wang, Yucheng
Shen, Xiujin
Zhou, Qin
Chen, Ying
Chen, Zhimin
Wu, Jianyong
Lin, Weiqiang
Shen, Yi
Qin, Jing
Xu, Hang
Xu, Feng
Wang, Junwen
Chen, Jianghua
Jiang, Hong
Huang, Hongfeng
Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
title Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
title_full Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
title_fullStr Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
title_full_unstemmed Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
title_short Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
title_sort correction: tacrolimus dose requirement based on the cyp3a5 genotype in renal transplant patients
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185064/
https://www.ncbi.nlm.nih.gov/pubmed/32363004
http://dx.doi.org/10.18632/oncotarget.27561
work_keys_str_mv AT qulihui correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT luyingying correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT yingmeike correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT libingjue correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT wengchunhua correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT xiezhoutao correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT liangludan correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT linchuan correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT yangxian correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT fengshi correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT wangyucheng correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT shenxiujin correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT zhouqin correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT chenying correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT chenzhimin correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT wujianyong correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT linweiqiang correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT shenyi correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT qinjing correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT xuhang correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT xufeng correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT wangjunwen correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT chenjianghua correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT jianghong correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients
AT huanghongfeng correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients